35 /100
HIGH RISK
Score updated Feb 26, 2026
NWBO
Northwest Biotherapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when NWBO's score changes →
📊 Score Breakdown
📋 Offering Ability
80
💰 Cash Runway
5
📊 Float Risk
95
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market CapN/A
Shares Outstanding1.54B
Float1.51B
CashN/A
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 724.0K shares
#1 Moloney Securities Asset Management, LLC 534.7K shares
#2 VSM Wealth Advisory, LLC 65.6K shares
#3 Opus Capital Group, LLC 60.1K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest57.44M
Days to Cover5.7
% of Float3.8%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account
📰 Recent News
Northwest Biotherapeutics: Q3 Earnings Snapshot Associated Press Finance · Nov 14
Northwest Biotherapeutics: Q2 Earnings Snapshot Associated Press Finance · Aug 14
Northwest Biotherapeutics: Q1 Earnings Snapshot Associated Press Finance · May 15
Track NWBO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NWBO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required